A more detailed examination of HSPH1 in NSCLC will assist in determining the precise mechanism through which HSPH1 contributes to cancer development, thereby enhancing the potential for utilising HSPH1 in clinical settings. This evidence concerns the gene HSPH1 and non-small cell lung carcinoma.